+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Mammalian Cell Fermentation Technology Market Report 2025

  • PDF Icon

    Report

  • 200 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 5991002
This Mammalian Cell Fermentation Technology market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The mammalian cell fermentation technology market size has grown rapidly in recent years. It will grow from $51.29 billion in 2024 to $57.48 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increased demand for biologics and biosimilars, increased focus on personalized medicine, increased output of biopharmaceuticals, and increased demand for scalable and effective cell culture methods.

The mammalian cell fermentation technology market size is expected to see rapid growth in the next few years. It will grow to $89.54 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to the increasing prevalence of chronic diseases, rising investments by multinational corporations, rising frequency of chronic diseases, increasing adoption of advanced bioprocessing techniques, increasing investment in research and development of novel recombinant proteins and growing demand for cancer therapies. Major trends in the forecast period include technological advancements in cell culture, technological advancements in bioreactor design, developing next-generation bioprocessing technologies, integration of multi-omics approaches, and technology-driven automation.

The increasing demand for biologics is anticipated to drive the growth of the mammalian cell fermentation technology market in the future. Biologics, which are medical products derived from living organisms or their components, are often used to treat diseases such as cancer, autoimmune disorders, and infectious diseases. The growing demand for biologics is driven by advancements in biotechnology, their effectiveness in treating prevalent chronic diseases, regulatory approvals, and increased investment in research and development. Mammalian cell fermentation technology is crucial for producing complex biologics, meeting the rising demand for personalized and targeted therapeutics. Its scalability, versatility, and ability to produce high-quality proteins foster innovation in the biopharmaceutical industry. For example, the National Library of Medicine reported in February 2024 that the Food and Drug Administration (FDA) approved 55 new drugs in 2023, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Therefore, the growing demand for biologics is driving the expansion of the mammalian cell fermentation technology market.

Major companies in the mammalian cell fermentation technology market are focusing on developing innovative solutions, such as mammalian cell culture, to strengthen their market position. Mammalian cell culture is an essential tool in various fields, including biomanufacturing, research, and regenerative medicine, as it facilitates the production of therapeutic proteins, vaccines, and functional cells or tissue analogs. For example, in June 2024, Syntegon, a Germany-based biotechnology company, introduced its new Modular Bioprocessing Platform (MBP) at Achema 2024. This cutting-edge platform is designed to address key challenges in biopharmaceutical production. The MBP is a highly flexible, fully integrated, and automated solution capable of supporting a range of applications, including microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The modular design of the MBP allows for reduced lead times and costs while maintaining high functionality and quality, adhering to the rigorous "made in Germany" standard. Additionally, the platform's prefabricated cleanroom design places all peripheral technology outside the cleanroom, enhancing efficiency and simplifying maintenance, making it an advanced solution in the mammalian cell fermentation technology market.

In February 2024, Chrysea Limited, an Ireland-based biotechnology company, acquired Rodon Biologics from the Iberfar Group for an undisclosed amount. With this acquisition, Chrysea aims to strengthen its synthetic biology and biopharmaceutical development capabilities by integrating Rodon Biologics' expertise in protein engineering, cell-line development, precision fermentation, downstream processing, formulation, analytics, and production. Rodon Biologics, a Portugal-based manufacturer of biological products, operates in mammalian cell fermentation technology.

Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc.

North America was the largest region in the mammalian cell fermentation technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mammalian cell fermentation technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Mammalian cell fermentation technology refers to the process of cultivating mammalian cells under controlled conditions to produce biopharmaceuticals, vaccines, or other biological products. This technology involves optimizing cell growth and protein expression in bioreactors or fermenters, ensuring the production of high-quality and consistent yields of desired therapeutic proteins or substances.

The main types of mammalian cell fermentation technology include Chinese hamster ovary (CHO) cell fermentation, human embryonic kidney (HEK) cell fermentation, baby hamster kidney (BHK) cell fermentation, murine myeloma cell fermentation, and other types. Chinese hamster ovary (CHO) cell fermentation is a biotechnological process used in the production of therapeutic proteins, such as monoclonal antibodies and recombinant proteins. The various applications of mammalian cell fermentation technology include monoclonal antibodies, recombinant proteins, vaccines, hormones, enzymes, and other products. The end-users of this technology include biopharmaceutical companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and academic and research institutes.

The mammalian cell fermentation technology market research report is one of a series of new reports that provides mammalian cell fermentation technology market statistics, including mammalian cell fermentation technology industry global market size, regional shares, competitors with a mammalian cell fermentation technology market share, detailed mammalian cell fermentation technology market segments, market trends, and opportunities, and any further data you may need to thrive in the mammalian cell fermentation technology industry. This mammalian cell fermentation technology research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mammalian cell fermentation technology market consists revenues earned by entities by providing services such as cell line development, process development, cell culture and fermentation, analytical and quality control services, and formulation and fill-finish services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mammalian cell fermentation technology market also includes of sales of biosimilars, cell and gene therapy products, diagnostic enzymes and proteins, and therapeutic proteins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Mammalian Cell Fermentation Technology Market Characteristics3. Mammalian Cell Fermentation Technology Market Trends and Strategies4. Mammalian Cell Fermentation Technology Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market
5. Global Mammalian Cell Fermentation Technology Growth Analysis and Strategic Analysis Framework
5.1. Global Mammalian Cell Fermentation Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis of End Use Industries
5.3. Global Mammalian Cell Fermentation Technology Market Growth Rate Analysis
5.4. Global Mammalian Cell Fermentation Technology Historic Market Size and Growth, 2019-2024, Value ($ Billion)
5.5. Global Mammalian Cell Fermentation Technology Forecast Market Size and Growth, 2024-2029, 2034F, Value ($ Billion)
5.6. Global Mammalian Cell Fermentation Technology Total Addressable Market (TAM)
6. Mammalian Cell Fermentation Technology Market Segmentation
6.1. Global Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chinese Hamster Ovary Cell Fermentation
  • Human Embryonic Kidney Cell Fermentation
  • Baby Hamster Kidney Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Other Types
6.2. Global Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Hormones
  • Enzymes
  • Other Applications
6.3. Global Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Companies
  • Contract Research Organizations and Contract Development and Manufacturing Organizations
  • Academic and Research Institutes
7. Mammalian Cell Fermentation Technology Market Regional and Country Analysis
7.1. Global Mammalian Cell Fermentation Technology Market, Split by Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Mammalian Cell Fermentation Technology Market, Split by Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Mammalian Cell Fermentation Technology Market
8.1. Asia-Pacific Mammalian Cell Fermentation Technology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Mammalian Cell Fermentation Technology Market
9.1. China Mammalian Cell Fermentation Technology Market Overview
9.2. China Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Mammalian Cell Fermentation Technology Market
10.1. India Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Mammalian Cell Fermentation Technology Market
11.1. Japan Mammalian Cell Fermentation Technology Market Overview
11.2. Japan Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Mammalian Cell Fermentation Technology Market
12.1. Australia Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Mammalian Cell Fermentation Technology Market
13.1. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Mammalian Cell Fermentation Technology Market
14.1. South Korea Mammalian Cell Fermentation Technology Market Overview
14.2. South Korea Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Mammalian Cell Fermentation Technology Market
15.1. Western Europe Mammalian Cell Fermentation Technology Market Overview
15.2. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Mammalian Cell Fermentation Technology Market
16.1. UK Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Mammalian Cell Fermentation Technology Market
17.1. Germany Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Mammalian Cell Fermentation Technology Market
18.1. France Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Mammalian Cell Fermentation Technology Market
19.1. Italy Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Mammalian Cell Fermentation Technology Market
20.1. Spain Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Mammalian Cell Fermentation Technology Market
21.1. Eastern Europe Mammalian Cell Fermentation Technology Market Overview
21.2. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Mammalian Cell Fermentation Technology Market
22.1. Russia Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Mammalian Cell Fermentation Technology Market
23.1. North America Mammalian Cell Fermentation Technology Market Overview
23.2. North America Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Mammalian Cell Fermentation Technology Market
24.1. USA Mammalian Cell Fermentation Technology Market Overview
24.2. USA Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Mammalian Cell Fermentation Technology Market
25.1. Canada Mammalian Cell Fermentation Technology Market Overview
25.2. Canada Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Mammalian Cell Fermentation Technology Market
26.1. South America Mammalian Cell Fermentation Technology Market Overview
26.2. South America Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Mammalian Cell Fermentation Technology Market
27.1. Brazil Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Mammalian Cell Fermentation Technology Market
28.1. Middle East Mammalian Cell Fermentation Technology Market Overview
28.2. Middle East Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Mammalian Cell Fermentation Technology Market
29.1. Africa Mammalian Cell Fermentation Technology Market Overview
29.2. Africa Mammalian Cell Fermentation Technology Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Mammalian Cell Fermentation Technology Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Mammalian Cell Fermentation Technology Market, Segmentation by End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Mammalian Cell Fermentation Technology Market Competitive Landscape and Company Profiles
30.1. Mammalian Cell Fermentation Technology Market Competitive Landscape
30.2. Mammalian Cell Fermentation Technology Market Company Profiles
30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Roche Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
31. Mammalian Cell Fermentation Technology Market Other Major and Innovative Companies
31.1. AGC Group
31.2. Lonza Group Ltd.
31.3. Boehringer Ingelheim GmbH
31.4. Catalent Inc.
31.5. Sartorius AG
31.6. Samsung Biologics Co. Ltd.
31.7. WuXi Biologics
31.8. Biocon Limited
31.9. Eppendorf AG
31.10. KBI Biopharma Inc.
31.11. Fujifilm Diosynth Biotechnologies
31.12. Avid Bioservices Inc.
31.13. BiOZEEN
31.14. Nordmark Pharma GmbH
31.15. Scorpius BioManufacturing Inc
32. Global Mammalian Cell Fermentation Technology Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Mammalian Cell Fermentation Technology Market34. Recent Developments in the Mammalian Cell Fermentation Technology Market
35. Mammalian Cell Fermentation Technology Market High Potential Countries, Segments and Strategies
35.1 Mammalian Cell Fermentation Technology Market in 2029 - Countries Offering Most New Opportunities
35.2 Mammalian Cell Fermentation Technology Market in 2029 - Segments Offering Most New Opportunities
35.3 Mammalian Cell Fermentation Technology Market in 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Mammalian Cell Fermentation Technology Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mammalian cell fermentation technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for mammalian cell fermentation technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mammalian cell fermentation technology market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Chinese Hamster Ovary Cell Fermentation; Human Embryonic Kidney Cell Fermentation; Baby Hamster Kidney Cell Fermentation; Murine Myeloma Cell Fermentation; Other Types
2) By Application: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Hormones; Enzymes; Other Applications
3) By End-Use: Biopharmaceutical Companies; Contract Research Organizations and Contract Development and Manufacturing Organizations; Academic and Research Institutes

Key Companies Mentioned: AbbVie Inc.; Thermo Fisher Scientific Inc; AstraZeneca PLC; Roche Holdings Inc.; Merck KGaA

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

The major companies featured in this Mammalian Cell Fermentation Technology market report include:
  • AbbVie Inc.
  • Thermo Fisher Scientific Inc
  • AstraZeneca PLC
  • Roche Holdings Inc.
  • Merck KGaA
  • AGC Group
  • Lonza Group Ltd.
  • Boehringer Ingelheim GmbH
  • Catalent Inc.
  • Sartorius AG
  • Samsung Biologics Co. Ltd.
  • WuXi Biologics
  • Biocon Limited
  • Eppendorf AG
  • KBI Biopharma Inc.
  • Fujifilm Diosynth Biotechnologies
  • Avid Bioservices Inc.
  • BiOZEEN
  • Nordmark Pharma GmbH
  • Scorpius BioManufacturing Inc

Table Information